Greenwich LifeSciences, Inc. (GLSI) Net Cash Provided by (Used in) Financing Activities USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Greenwich LifeSciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2021 to 2024.
  • Greenwich LifeSciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $299 K.
  • Greenwich LifeSciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$7.54 M, a 366% decline from 2021.
  • Greenwich LifeSciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $2.84 M, a 90.5% decline from 2020.
  • Greenwich LifeSciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $29.8 M, a 13763% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $299 K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q1 2022 -$5.51 M -$7.79 M -343% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q1 2021 $2.27 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.